Seroprevalence of SARS-CoV-2 antibodies and knowledge, attitude and practice toward COVID-19 in the Republic of Srpska-Bosnia & Herzegovina: A population-based study

The aim of the study was to assess the seroprevalence of SARS-CoV-2 in the Republic of Srpska, Bosnia and Herzegovina, and to analyse the knowledge, attitudes and practices of the population toward COVID-19. This population-based study was conducted in a group of 1,855 randomly selected individuals...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2022-01, Vol.17 (1), p.e0262738-e0262738
Main Authors: Bokonjic, Dejan, Knezevic, Darija, Acimovic, Jela, Puhalo-Sladoje, Dragana, Masic, Srdjan, Zeljkovic, Branislav, Petkovic, Miroslav, Skrbic, Ranko, Djakovic-Devic, Jelena, Spaic, Dragan, Mijovic, Biljana
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies
Antibodies, Viral - blood
Attitudes
Biology and life sciences
Bosnia and Herzegovina
Bosnia and Herzegovina - epidemiology
Child
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - immunology
COVID-19 - psychology
Distribution
Enzyme-linked immunosorbent assay
Epidemics
Evaluation
Female
Health attitudes
Health Knowledge, Attitudes, Practice
Health risks
Households
Humans
Infant
Infections
Laboratories
Male
Management
Medicine and Health Sciences
Middle Aged
Municipalities
People and Places
Population studies
Population-based studies
Prevalence studies (Epidemiology)
Research and Analysis Methods
SARS-CoV-2 - physiology
Seroepidemiologic Studies
Serology
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Vaccination
Vaccines
Viral diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of the study was to assess the seroprevalence of SARS-CoV-2 in the Republic of Srpska, Bosnia and Herzegovina, and to analyse the knowledge, attitudes and practices of the population toward COVID-19. This population-based study was conducted in a group of 1,855 randomly selected individuals from all municipalities from 1 December 2020 to 15 January 2021. All individuals were asked to sign a consent form and to fill in a questionnaire, following which a blood samples were collected. Total anti-SARS-CoV-2 antibodies were determined in serum specimens using the total Ab ELISA assay. The overall seroprevalence rate was 40.3%. Subjects aged
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0262738